{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:12:54Z","timestamp":1795104774798,"version":"4.10.3"},"reference-count":39,"publisher":"American Society of Hematology","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The detection of genetic aberrations is crucial for early therapy decisions in acute myeloid leukemia (AML) and recommended for all patients. Because genetic testing is expensive and time consuming, a need remains for cost-effective, fast, and broadly accessible tests to predict these aberrations in this aggressive malignancy. Here, we developed a novel fully automated end-to-end deep learning pipeline to predict genetic aberrations directly from single-cell images from scans of conventionally stained bone marrow smears already on the day of diagnosis. We used this pipeline to compile a multiterabyte data set of &amp;gt;2 000 000 single-cell images from diagnostic samples of 408 patients with AML. These images were then used to train convolutional neural networks for the prediction of various therapy-relevant genetic alterations. Moreover, we created a temporal test cohort data set of &amp;gt;444 000 single-cell images from further 71 patients with AML. We show that the models from our pipeline can significantly predict these subgroups with high areas under the curve of the receiver operating characteristic. Potential genotype-phenotype links were visualized with 2 different strategies. Our pipeline holds the potential to be used as a fast and inexpensive automated tool to screen patients with AML for therapy-relevant genetic aberrations directly from routine, conventionally stained bone marrow smears already on the day of diagnosis. It also creates a foundation to develop similar approaches for other bone marrow disorders in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011076","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T17:00:44Z","timestamp":1700067644000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears"],"prefix":"10.1182","volume":"8","author":[{"given":"Jacqueline","family":"Kockwelp","sequence":"first","affiliation":[{"name":"1Institute for Geoinformatics, University of M\u00fcnster, M\u00fcnster, Germany"},{"name":"2Institute for Computer Science, University of M\u00fcnster, M\u00fcnster, Germany"},{"name":"3Centre of Reproductive Medicine and Andrology, Institute of Reproductive and Regenerative Biology, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Thiele","sequence":"additional","affiliation":[{"name":"1Institute for Geoinformatics, University of M\u00fcnster, M\u00fcnster, Germany"},{"name":"2Institute for Computer Science, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannis","family":"Bartsch","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-6333","authenticated-orcid":false,"given":"Lars","family":"Haalck","sequence":"additional","affiliation":[{"name":"1Institute for Geoinformatics, University of M\u00fcnster, M\u00fcnster, Germany"},{"name":"2Institute for Computer Science, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Gromoll","sequence":"additional","affiliation":[{"name":"3Centre of Reproductive Medicine and Andrology, Institute of Reproductive and Regenerative Biology, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schlatt","sequence":"additional","affiliation":[{"name":"3Centre of Reproductive Medicine and Andrology, Institute of Reproductive and Regenerative Biology, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Exeler","sequence":"additional","affiliation":[{"name":"5Institute of Human Genetics, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalen","family":"Bleckmann","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"6Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Steffen","sequence":"additional","affiliation":[{"name":"6Department of Medicine II, University Hospital Frankfurt, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-6567","authenticated-orcid":false,"given":"Wolfgang E.","family":"Berdel","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schliemann","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-4029","authenticated-orcid":false,"given":"Benjamin","family":"Risse","sequence":"additional","affiliation":[{"name":"1Institute for Geoinformatics, University of M\u00fcnster, M\u00fcnster, Germany"},{"name":"2Institute for Computer Science, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-9910","authenticated-orcid":false,"given":"Linus","family":"Angenendt","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, University Hospital M\u00fcnster, M\u00fcnster, Germany"},{"name":"7Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"4","key":"2024010914085428900_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2024010914085428900_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","article-title":"Acute myeloid leukemia, version 3.2019, NCCN Clinical Practice Guidelines in oncology","volume":"17","author":"Tallman","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"6","key":"2024010914085428900_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.annonc.2020.02.018","article-title":"Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Heuser","year":"2020","journal-title":"Ann Oncol"},{"issue":"20","key":"2024010914085428900_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"9825","key":"2024010914085428900_bib5","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(12)60485-1","article-title":"Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study","volume":"379","author":"Castaigne","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"2024010914085428900_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1470-2045(14)70281-5","article-title":"Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials","volume":"15","author":"Hills","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"2024010914085428900_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2024010914085428900_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.19.01406","article-title":"Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia: early results from the Prospective Randomized AMLSG 09-09 Phase III Study","volume":"38","author":"Schlenk","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"10388","key":"2024010914085428900_bib9","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(23)00464-6","article-title":"Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Erba","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"2024010914085428900_bib10","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3026(23)00089-3","article-title":"Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial","volume":"10","author":"D\u00f6hner","year":"2023","journal-title":"Lancet Haematol"},{"issue":"26","key":"2024010914085428900_bib11","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2024010914085428900_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood-2006-03-014340","article-title":"High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations (\"cuplike\" nuclei)","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2024010914085428900_bib13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood-2016-06-720169","article-title":"Folding two lobes, you don't get a cup?","volume":"128","author":"Mikesch","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2024010914085428900_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood.2020008211","article-title":"How I diagnose and treat NPM1-mutated AML","volume":"137","author":"Falini","year":"2021","journal-title":"Blood"},{"issue":"29","key":"2024010914085428900_bib15","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1200\/JCO.19.00416","article-title":"Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: a pooled analysis of individual patient data from Nine International Cohorts","volume":"37","author":"Angenendt","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"2024010914085428900_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.2022018582","article-title":"Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification","volume":"141","author":"Angenendt","year":"2023","journal-title":"Blood"},{"issue":"9","key":"2024010914085428900_bib17","doi-asserted-by":"crossref","first-page":"e0223013","DOI":"10.1371\/journal.pone.0223013","article-title":"Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy","volume":"14","author":"Ballo","year":"2019","journal-title":"PLoS One"},{"issue":"13","key":"2024010914085428900_bib18","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2012-10-462440","article-title":"Significance of FAB subclassification of \"acute myeloid leukemia, NOS\" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients","volume":"121","author":"Walter","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2024010914085428900_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024010914085428900_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41591-021-01343-4","article-title":"Deep learning in histopathology: the path to the clinic","volume":"27","author":"van der Laak","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"2024010914085428900_bib21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2021.04.002","article-title":"Artificial intelligence for clinical oncology","volume":"39","author":"Kann","year":"2021","journal-title":"Cancer Cell"},{"issue":"10","key":"2024010914085428900_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"2024010914085428900_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"2024010914085428900_bib24","doi-asserted-by":"crossref","first-page":"e1002730","DOI":"10.1371\/journal.pmed.1002730","article-title":"Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study","volume":"16","author":"Kather","year":"2019","journal-title":"PLoS Med"},{"issue":"8","key":"2024010914085428900_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s43018-020-0087-6","article-title":"Pan-cancer image-based detection of clinically actionable genetic alterations","volume":"1","author":"Kather","year":"2020","journal-title":"Nat Cancer"},{"issue":"10221","key":"2024010914085428900_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(19)32998-8","article-title":"Deep learning for prediction of colorectal cancer outcome: a discovery and validation study","volume":"395","author":"Skrede","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"2024010914085428900_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(20)30535-0","article-title":"Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study","volume":"22","author":"Yamashita","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"2024010914085428900_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s42256-019-0101-9","article-title":"Human-level recognition of blast cells in acute myeloid leukaemia with convolutional neural networks","volume":"1","author":"Matek","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"20","key":"2024010914085428900_bib29","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1182\/blood.2020010568","article-title":"Highly accurate differentiation of bone marrow cell morphologies using deep neural networks on a large image data set","volume":"138","author":"Matek","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2024010914085428900_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41375-021-01408-w","article-title":"Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears","volume":"36","author":"Eckardt","year":"2022","journal-title":"Leukemia"},{"key":"2024010914085428900_bib38","first-page":"8026","volume-title":"NIPS'19: Proceedings of the 33rd International Conference on Neural Information Processing Systems","author":"Paszke","year":"2019"},{"key":"2024010914085428900_bib31","author":"Kockwelp","year":"2022"},{"key":"2024010914085428900_bib32","first-page":"770","author":"He","year":"2016"},{"key":"2024010914085428900_bib33","author":"Loshchilov","year":"4  2019"},{"key":"2024010914085428900_bib34","author":"Zeiler","year":"2013"},{"key":"2024010914085428900_bib35","author":"Simonyan","year":"2014"},{"key":"2024010914085428900_bib39","author":"R Core Team","year":"2018"},{"issue":"10","key":"2024010914085428900_bib36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2024010914085428900_bib37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 ELN recommendations from an International Expert Panel","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/70\/2180456\/blooda_adv-2023-011076-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/70\/2180456\/blooda_adv-2023-011076-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T09:09:22Z","timestamp":1704791362000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/1\/70\/498751\/Deep-learning-predicts-therapy-relevant-genetics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011076","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}